We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Molecular Analysis Tool to Improve Disease Diagnosis

By LabMedica International staff writers
Posted on 05 Nov 2025

Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional variations. More...

Traditional approaches like ELISA or mass spectrometry require labeling or complex processing and can miss minute molecular differences. Now, researchers have developed a label-free analytical method called voltage-matrix nanopore profiling, which can classify biomolecules based on their intrinsic electrical signatures.

The breakthrough by researchers from The University of Tokyo (Tokyo, Japan) combines multivoltage solid-state nanopore recordings with machine learning to create a multidimensional map of molecular signals. Their research, published in Chemical Science, demonstrate how this technique can identify and classify proteins in complex mixtures without modification, paving the way for next-generation molecular diagnostics.

Solid-state nanopores act as nanoscale tunnels through which individual molecules pass, driven by ionic current. By systematically varying the voltage, the team recorded how protein molecules interacted with the nanopores under different electrical conditions. These measurements formed a voltage matrix, which captured both stable and voltage-sensitive features of each molecule. Machine learning algorithms then analyzed these features to accurately classify and distinguish proteins, even when they were mixed together.

To validate their approach, the researchers analyzed mixtures containing two cancer-related biomarkers: carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3). Using six voltage conditions, they constructed distinct signal patterns that reliably differentiated each protein. The technique also detected molecular changes when CEA bound with an aptamer—a short, synthetic DNA sequence—demonstrating its sensitivity to subtle structural alterations.

In another test using mouse serum samples, the voltage-matrix framework successfully distinguished between centrifuged and non-centrifuged sera, confirming its potential for real-world diagnostic use. The method revealed compositional differences invisible to conventional single-voltage nanopore measurements, underscoring its ability to uncover molecular diversity in complex biological fluids.

By integrating physics, nanotechnology, and artificial intelligence, this new analytical framework offers a powerful tool for understanding molecular individuality—the unique electrical signature of each molecule. It holds promise for biomedical applications ranging from disease diagnosis to environmental monitoring, providing a foundation for high-resolution, real-time molecular profiling.

“By systematically varying voltage conditions and applying machine learning, we can create a voltage matrix that reveals both robust, voltage-independent molecular features and voltage-sensitive structural changes,” said Professor Sotaro Uemura. “Our study is not simply about improving detection sensitivity — it establishes a new way to represent and classify molecular signals across voltages, allowing us to visualize molecular individuality and estimate compositions within mixtures.”

Related Links:
The University of Tokyo


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.